These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10309292)

  • 41. The effect of drug information leaflets on patient behavior.
    Vinker S; Eliyahu V; Yaphe J
    Isr Med Assoc J; 2007 May; 9(5):383-6. PubMed ID: 17591379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 43. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Requirements for FDA-approved patient information spelled out in final rule.
    Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523
    [No Abstract]   [Full Text] [Related]  

  • 45. Information search activities among elderly prescription drug users.
    Morris LA; Grossman R; Barkdoll G; Gordon E; Chun MY
    J Health Care Mark; 1987 Dec; 7(4):5-15. PubMed ID: 10285778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do pictograms improve children's understanding of medicine leaflet information?
    Hämeen-Anttila K; Kemppainen K; Enlund H; Bush Patricia J; Marja A
    Patient Educ Couns; 2004 Dec; 55(3):371-8. PubMed ID: 15582343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medicine. Magic bullet gone astray: medications and the Internet.
    Veronin MA; Youan BB
    Science; 2004 Jul; 305(5683):481. PubMed ID: 15273381
    [No Abstract]   [Full Text] [Related]  

  • 48. Redefining appropriate use of antibiotics.
    Gums JG
    Am Fam Physician; 2004 Jan; 69(1):35, 39-40. PubMed ID: 14727818
    [No Abstract]   [Full Text] [Related]  

  • 49. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
    Spencer HM
    Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
    [No Abstract]   [Full Text] [Related]  

  • 50. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
    Hochhauser M
    Manag Care Q; 2002; 10(3):6-10. PubMed ID: 12476659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FDA chief says demand by patients for more drug information is genuine.
    Health Educ Rep; 1980 Jul; 2(15):4-5. PubMed ID: 10247629
    [No Abstract]   [Full Text] [Related]  

  • 53. Be wary of recommending off-label use of meds.
    Luttrull S
    Adv Nurse Pract; 2001 Feb; 9(2):18. PubMed ID: 12416047
    [No Abstract]   [Full Text] [Related]  

  • 54. Provision of prescription drug info mandated.
    Marwick C
    JAMA; 1996 Sep; 276(12):935. PubMed ID: 8805713
    [No Abstract]   [Full Text] [Related]  

  • 55. Importing prescription drugs: risky business.
    Hassel L; Arzuaga P
    Empl Benefits J; 2003 Dec; 28(4):83-6. PubMed ID: 14712740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient package inserts: goals versus achievements.
    Lasagna L
    Drug Ther; 1982; ():181-9. PubMed ID: 7105992
    [No Abstract]   [Full Text] [Related]  

  • 57. Encouraging trend on prescription drug information.
    Marwick C
    JAMA; 1997 Jun; 277(22):1746-7. PubMed ID: 9178774
    [No Abstract]   [Full Text] [Related]  

  • 58. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 59. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
    Hayslip D
    Nephrol Nurs J; 2008; 35(2):163-7. PubMed ID: 18472685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.